Liquidia Technologies' Series D - II Round

Liquidia Technologies raised a round of funding on February 20, 2018.

Liquidia Technologies (NASDAQ: LQDA) is a late-stage clinical biopharmaceutical company that is focused on improving the performance of medicines by precisely engineering drug particles. Liquidia's pr…

Articles about Liquidia Technologies' Series D - II Round: